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A 64-year-old normotensive non-diabetic smoker with no signiﬁ-
cant past medical or family history was hospitalized on 31 Decem-
ber 2013 for Acute Coronary Syndromewith ECG changes of T #in II,
III, aVF besides echocardiographic features of inferior wall hypo-
kinesia and LVEF of 55%. He was then managed medically with
uneventful recovery followed by development of effort angina a
fortnight later. Coronary angiography done on 23 January 2014
revealed triple vessel disease for which he was advised coronary
artery bypass graft surgery but he refused and hence coronary
angioplasty with implantation of drug eluting stents Endeavor
SprintTM 3  30! LAD, Yukon Choice FlexTM 3  24! LCx and
bare metal stent DriverTM 3.5  30! RCA was carried out in the
same sitting with good results. He apparently remained asympto-
matic till May 2015 when he developed a recurrence of effort
angina. ECG and Echo ﬁndings were unchanged while his coronary
angiogram done on 02 May 2015 revealed patent stents in LAD and
LCx and diffuse in-stent restenosis (ISR) in the RCA stent along
with a large saccular aneurysm in the proximal part. PCI with
implantation of drug eluting stent Xience ProTM3.5  28! distal
part of the ISR alongwith a covered stent PrograftTM 3.5  23! the
aneurysmal segment was done successfully. Coronary artery
aneurysms (CAA) was frequently reported after drug-eluting stent
(DES);within BMS it is rare at 0.2–1.5%. Stent implantation may
affect the normal healing process of the vessel wall and the
remodeling process may lead to CAA. CAA can cause coronary
ischemia as a result of thrombosis from motionless blood ﬂow,
distal coronary embolism or vasospasm or even rupture causing
sudden death. Covering the CAA with Coronary Graft Stent
implantation can successfully seal the aneurysm and serves a safe
curative solution.
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A 56-year-old female suffering from end stage renal disease on
maintenance hemodialysis with access through a left brachioce-
phalic arteriovenous prosthetic graft, developed mild swelling of
the left arm and evaluation revealed ﬁrm cord like feel of the graft
with absence of thrill and bruit, suggestive of thrombotic occlusion
of the graft which was conﬁrmed by Doppler. A catheter based
interventional approach to open the thrombosed graft was
attempted. After administering 300 mg of oral disprin, vascular
access was obtained through the left radial artery using a 5 French
sheath and the spasmolytic cocktail of 5000 units of heparin, 8 mg
of nicorandil and 200 mg of nitroglycerine was administered. An
angiogram was done which revealed total occlusion of the graft
from the brachial artery. Through a 5 F JR 4 guide catheter, a Cross It
100 PTCA guide wire was passed from the left brachial artery
through the prosthetic graft till the left subclavian vein and serial
dilatation of the entire length of the graft was done with 2  10
Sapphire PTCA balloon catheter, resulting in partial revasculariza-
tion. Thereafter, the guide catheter was passed into the graft and
streptokinase 1,25,000 units bolus followed by 10,000 units/h infu-
sion was commenced and continued for 24 h followed by heparin
5000 units bolus followed by 1000 units/h infusion for another 24 h.
The graft felt soft with return of thrill and bruit and a check
angiogram revealed complete patency of the graft. Oral anticoa-
gulation with warfarin was commenced. Catheter-based interven-
tions are successful in restoring ﬂow in more than 80% of
hemodialysis accesses that undergo thrombosis and have replaced
surgical revision as the treatment of choice for thrombosed
accesses.
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Aims: We sought to evaluate the immediate and midterm clinical
outcomes following bioresorbable vascular scaffold (BVS) implan-
tation in diabetic patients.
Methods and results: We collected the data of all consecutive
diabetic patients who underwent PCI with everolimus-eluting
BVS implantation at our center from December 2012 to December
2014. We have used 58 BVS in 54 patients. All patients were
preloaded with clopidogrel 600 mg or prasugrel 60 mg along with
aspirin and were maintained on DAPT for 1 year after the proce-
dure. The primary end point was procedural success. Furthermore,
we evaluated the occurrence of cardiac death, target lesion revas-
cularization (TLR) and BVS thrombosis at follow-up. Clinical data
were collected by hospital visit or telephone contact at 2 month
intervals.
Of the 722 patients that had undergone PCI during the study period,
BVS were implanted in 54 (7.4%) diabetic patients. Of these 54
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